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Abstract 
The thesis entitled “Design, Synthesis, Conformational Analysis and Biological 
Studies of Peptides containing Nucleoside and Sugar Amino Acids” consists of 
three chapters. 
CHAPTER I: Describes the synthesis and conformational analysis of mannose-
derived furanoid sugar amino acid based linear peptides. 
CHAPTER II: Deals with the synthesis, conformational analysis and biological 
evaluation of novel cyclic cationic antimicrobial peptides containing sugar amino 
acids. 
This chapter is divided into two parts: 
Part A: Describes the synthesis and conformational studies of sugar amino acid based 
cyclic peptides stabilized by intramolecular H-bonding. 
Part B: Describes the synthesis and biological studies of cyclic cationic antimicrobial 
peptides containing sugar amino acids. 
CHAPTER III: Describes the synthesis and conformational studies of cyclic 
homooligomers of nucleoside amino acid. 
 
CHAPTER I 
  
Synthesis and conformational analysis of mannose-derived furanoid sugar amino 
acid based linear peptides 
 
The conformational ordering of protein leading to its unique three-dimensional 
architecture is intriguing to chemists over the years. As the function of protein resides 
on its three dimensional conformation, syntheses of new non-natural scaffolds and 
their foldamers leading to the conformationally restricted pharmacophore could be 
suited for the biomedical applications. Sugar amino acid (SAA), in this context is an 
attractive tool in the peptidomimetic research. The functional group versatility, easy 
availability and sterioisomer specificity represent SAA as one of the major 
peptidomimetic molecular frameworks to design conformationally restrained ordered 
models for studying biological interactions. 
We report the synthesis of sugar amino acid, methyl N-Boc-6-amino-2,5-
anhydro-3,4-di-O-benzyl-6-deoxy-D-mannonate (Maa) 1 and the conformational 
biases imposed by the Maa residues in the linear oligomeric peptides 2-5 having 
repeat units of Maa(Bn2)-Phe-Leu. 
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Figure 1 
 
 
 Our synthesis started with methyl N-Boc-6-amino-2,5-anhydro-3,4-di-O-
benzyl-6-deoxy-D-mannonate (Maa) 1,  which was prepared from D-mannitol 6 
following reported procedure. Scheme 1 delineates the synthesis. Saponification of 1 
with LiOH.H2O in THF:MeOH:H2O (3:1:1) gave the carboxylic acid 13. The 
coupling between 13 and H-Phe-Leu-OMe under the standard peptide coupling 
conditions using EDCI, HOBT and DIPEA in DCM gave the tripeptide Boc-
Maa(Bn2)-Phe-Leu-OMe 2 in 70% yield (Scheme 1). 
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Scheme 1 
 
 
Next, the tripeptide 2 was divided into two equimolar quantities. 
Saponification of one-half with LiOH.H2O in THF:MeOH:H2O (3:1:1) gave the 
carboxylic acid 14. The other equivalent quantity of 2 was treated with trifluoroacetic 
acid in CH2Cl2 to give the Boc-deprotected product 15. (Scheme 2). The coupling 
between 14 and 15 under standard peptide coupling conditions furnished hexapeptide 
3 in 70% yield (Scheme 2). 
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Scheme 2 
 
Now the hexapeptide 3 was divided into three equimolar quantities. 
Saponification of two-half quantity separately with LiOH.H2O in THF:MeOH:H2O 
(3:1:1) gave the carboxylic acid 16. The other equivalent quantity of 3 was treated 
with trifluoroacetic acid in CH2Cl2 to give the Boc-deprotected product 17 (Scheme 
3). 
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By coupling 16 with 15 and 16 with 17 under standard peptide coupling 
conditions we got 4 and 5, respectively in 60% yields (Scheme 4). 
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Scheme 4 
 
Conformational analysis of 2-5 was carried out by extensive NMR studies 
including TOCSY and ROESY experiments and molecular dynamics (MD) studies. 
Both 2 and 3 have a well-defined structure in CDCl3 with repeating pseudo β-turns, 
each involving a 10-membered ring structure with intramolecular hydrogen bonds 
between PheNH → C=Oi−2. 4 and 5 aggregates to a novel antiparallel double helical 
structures. The 2,5-trans geometry of Maa leading to the significant twists in the 
direction of the chain propagation might have resulted the helical conformation, 
which is further stabilized by the extensive intermolecular hydrogen bonding that 
enforces the nucleation of two strands in antiparallel motif. 
  
 
 
 
 
 
 
 
Figure 2. Stereo-view of 10 lowest energy superimposed MD structures of 5 (left) and its top view 
(right). The benzyl groups and the amino acid side-chains are not shown for clarity. 
 
In conclusion, peptides containing sugar amino acid exist as antiparallel 
double helical fashion resembling the structural feature of Gramicidin A could be the 
model for new antibiotic. 
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CHAPTER II 
Synthesis, conformational analysis and biological evaluation of novel cyclic 
cationic antimicrobial peptides containing sugar amino acids 
 
In our continuous combat against virulent pathogenic bacteria, development of 
new antibiotics with novel modes of action assumes great significance today. Easily 
curable bacterial diseases are now-a-days becoming life threatening owing to the 
increasing resistance of pathogens to established drugs. Cationic antimicrobial 
peptides (CAPs) are long considered as potential alternative antibiotics. Both linear 
and cyclic cationic peptides have been found as the part of innate immune response of 
many vertebrates including humans. These compounds exhibit a primary defense 
system of the host and are believed to be fighting against bacteria by disrupting their 
cell membrane through pore formation. These cationic antimicrobial peptides (CAPs) 
are having either α-helical (e. g. magainins, mellitin) or β-sheet (e. g. gramicidin S, 
tachyplesins) structure and are amphiphilic in nature. However, due to the hemolytic 
activity of these natural antibiotics towards the human blood cells with comparable 
efficiency, their uses as therapeutic agents are restricted. Medicinal chemists are thus 
very keen to have new CAP antibiotics either with new scaffolds or by mimicking the 
natural counterparts. 
Sugar amino acids (SAAs) by virtue of its versatile functionalities could be 
useful scaffolds for peptide antibiotic research. We intended to synthesize cyclic 
cationic antimicrobial peptides, whose cyclic frame will be rigidified by 
intramolecular H-bonding and the peptides will be amphiphilic, i.e., there will be 
segregation of hydrophobic and hydrophilic part onto separate surfaces. 
       
Part A: Synthesis and conformational studies of sugar amino acid based cyclic 
peptides stabilized by intramolecular H-bonding. 
 
 In this part we did approach to design and synthesize cyclic compounds that 
could exhibit secondary structure through intramolecular H-bonding. Herein we 
describe the synthesis of cyclic peptides 1-2, containing sugar amino acid 3 (Figure 
1). These cyclic peptides were studied in detail for their conformational preferences.  
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Figure 1 
 
Our synthesis started from (2S)-5-oxotetrahydro-2-furancarboxylic acid 5, 
which was prepared from L-glutamic acid 4, following the reported procedure 
(Scheme 1). The compound 5 was reduced to alcohol 6 in 78% yield, upon treatment 
with borane-dimethyl sulfide in anhydrous THF at 0 ºC to room temperature. 
Protection of the primary alcohol by using TrCl and Et3N with catalytic DMAP in 
DCM furnished 7 in 77% yield. Lactone was selectively reduced to inseparable 
anomeric mixture of lactol 8 using DIBAL-H in 86% yield. Acetylation of anomeric 
alcohol using Ac2O, Et3N gave 9 in 96% yield.  9 was treated with trimethylsilyl 
cyanide in the presence of BF3:Et2O to give a diastereomeric mixture of the glycosyl 
cyanides 10, in 64% yield. Treatment of compound 10 with LiAlH4 in refluxing 
condition in THF resulted the primary amine, which was in situ protected with Boc2O 
to furnish 11 (α:β, 45:30) in 75% yield. Finally, two steps oxidation of primary 
alcohol of 11 followed by treatment with CH2N2 resulted in the formation of 12 (88% 
yield). Saponification of 12 with LiOH.H2O in THF:MeOH:H2O (3:1:1) gave the 
sugar amino acid 3. The coupling between 3 and H-Phe-Leu-OMe under the standard 
peptide coupling conditions using EDCI, HOBT and DIPEA in DCM gave the 
tripeptide Boc-SAA-Phe-Leu-OMe 13 in 75% yield (Scheme 1). 
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Scheme 1 
 
Saponification of compound 13 was performed with LiOH.H2O in 
THF:MeOH:H2O (3:1:1) to furnish the acid 14. Next, the crude acid 14 was treated 
with TFA in CH2Cl2, to give the TFA-salt 15 (Scheme 2). When the TFA-salt 15 was 
treated with pentaflouro diphenyl phosphinate (FDPP) and DIPEA in dry acetonitrile 
(10-3 M) at 0 °C to room temperature, it underwent cyclodimerization reaction to give 
1, the only isolated product in 60% yield (Scheme 2) 
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Scheme 2 
 
To reproduce this cyclodimerisation reaction, another analogue 2 was also 
prepared. For that, 3 was coupled with H-Leu-Val-OMe to get tripeptide 16. 
Following the above-mentioned procedure 16 was cyclodimerised to furnish 2 
(scheme 3). 
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 The NMR spectra of the cyclic products displayed symmetrical structures. 
Detailed NMR studies in CDCl3 and subsequent constrained MD simulations revealed 
that 1 and 2 displayed well-defined distorted “β-β corner” structures where both 
PheNH and SAANH in 1 and LeuNH and SAANH in 2 are H-bonded and each 24 
membered macrocyclic ring is stabilized by four intramolecular H-bonds (Figure 2).   
 
 
 
 
 
 
 
 
 
Figure 2. Lowest energy structure of 1 (left) and 2 (right) obtained from MD calculations. 
 
Part B: Synthesis and biological studies of cyclic cationic antimicrobial peptides 
containing sugar amino acids. 
 
In previous part of this chapter we synthesized well-defined intramolecularly 
hydrogen-bonded furanoid sugar amino acid based rigid cyclic peptides as basic 
frame. Our next target was to impose amphiphilic nature to those secondary structured 
cyclic peptides by distributing the hydrophobic and hydrophilic residues onto separate 
surfaces, which is pre-requisite for peptides to act as CAPs. Knowing its 
conformational features we anticipated that tuning in the sugar amino acids with 
suitable functionalities could lead to the generation of novel amphiphilic structures to 
our cyclic compounds. 
We report here synthesis, conformational analysis of a set of cyclic peptides 
(19-21) that are potentially active against bacteria. 
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Figure 3 
 
The functionally tuned building blocks 22a and 22b were used to synthesize 
the cyclic compounds. Introduction of an extra amino group in C-4 position of SAA 
ring was our interest from synthetic point of view. We were also interested to devise a 
common strategy to synthesize these two diasteriomeric SAAs from the same starting 
material. Our synthesis of the building block 22 started from 26, which was prepared 
from D-xylose (23) following literature procedure (Scheme 4). The 1,2-O-
isopropylidene group of 26 was methanolyzed upon treatment with dry HCl in MeOH 
to yield both the anomers 27a-b of methyl-3,5-di-O-benzyl-D-xylofuranoside in a 
ratio of 2:3 (α:β), respectively. The C-2 hydroxyl was etherified using MeI, NaH and 
catalytic amount of TBAI. Next the compound was treated with 20% 1NHCl-AcOH 
and heated at 60 °C for 2h. The hemiacetal was acetylated to 30 without any further 
purification using Ac2O/Et3N. The inseparable anomers (30) were treated with TMS-
CN in presence of BF3-Et2O to furnish 31 as anomeric mixture. Conversion of CN to 
aldehyde using DIBAL-H, oxidation and treatment with CH2N2 resulted 32a-b (5:4) 
in 72% yield (Scheme 4). The anomers could easily be separated through silica gel 
column chromatography. The next reactions of these isomers were performed 
separately. 
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Scheme 4 
 
Complete debenzylation followed by selective TBDPS protection to primary 
hydroxyl yielded 34a-b. Our next target was to introduce azido group to C-4 center. 
C-4 hydroxyl was reacted with Tf2O. The resulting triflate, after flash 
chromatography was treated with 6 eqv. of NaN3 in dry DMF at -5 °C to furnish γ 
azido ester 35a-b. The azido group was hydrogenated in the subsequent step and the 
resulting amino group was protected in situ by Boc2O to yield 36a-b. Little 
elimination was observed in α-anomer that was inseparable from 35a. However, the 
eliminated product could be separated in 8% yield in its saturated form in the next 
step. Primary silyl deprotection using TBAF afforded 37a-b. Tosylation of the 
primary hydroxyl group and upon heating the tosylated intermediate with NaN3 in 
DMF at 65 °C yielded SAAs 22a-b (Scheme 5). 
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Scheme 5 
 
Synthesis of cyclic framework of the target molecules is described in Scheme 
6. Saponification of SAA 22a-b followed by coupling with H-Phe-Leu-OMe using 
EDCI and HOBt afforded 39a-b in 85% yield. Stepwise saponification of 39a-b 
followed by hydrogenation of azido to amine yielded the crude tripeptide which on 
the subsequent step were cyclodimerised using FDPP in CH3CN under dilute 
condition (2 x 10-3 M) to furnish 42a-b in 60-65% yield. Removal of Boc using TFA 
in DCM afforded 19a-b in quantitative yield (Scheme 6). 
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Scheme 6 
 
19a-b were separately coupled with Boc-hGly-OH and Boc-Lys(Boc)-OH to 
furnish 43a-b and 44a-b, respectively, following the procedure stated earlier. Finally 
global Boc-deprotection of each compound furnished 20a-b and 21a-b in quantitative 
yields (Scheme 7). 
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Scheme 7 
 
 The compounds 19a-b, 20a-b and 21a-b were bacteriolytic. The antibacterial 
activity of the compounds was examined against E. coli and S. aureus.  The 
compounds with (2S) configuration in SAA were more active against E. coli and S. 
aureus as compared to the compounds where the SAA was (2R). The presence of –
NH2 groups and hydrophobicity provided by the Leu and Phe side chains, imparted 
cell-surface disrupting properties as observed for cationic antibacterial peptides. 
Antibacterial activities were at lower concentration compared to hemolytic activity. 
 
In conclusion, novel cyclic cationic peptides containing sugar amino acids 
were synthesized and they were found to act against bacteria. The higher 
antimicrobial activity and lower hemolytic activity could make them attractive tools 
for the rational design of antibiotic.  
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CHAPTER III 
 Synthesis and conformational studies of cyclic homooligomers of nucleoside 
amino acid. 
 
Cyclisation of linear biopolymers is widely used to constrain their 
conformational degrees of freedom and induce desirable structural biases permitting 
enhanced receptor selectivity and binding affinity with additional properties like 
decreased susceptibility to degradation in biological systems. Cyclic DNAs and 
RNAs, for example, have been studied extensively for their unusual chemical and 
biological activities. However, synthesis of such cyclic DNAs remains a challenging 
task, thereby limiting exploratory studies, especially in discovering potential leads for 
drug discovery. It was envisaged that the replacement of the phosphodiester linkages 
with amide bonds would not only facilitate the assembly of such substrates using 
standard solid- or solution-phase peptide synthesis methods, but would also help to 
enhance their stability towards nucleases. 
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Amide-linked oligonucleotides have been studied extensively for potential 
therapeutic applications involving antisense strategy. However, their cyclic versions 
have remained largely unexplored. Herein, we describe the synthesis of amide-linked 
cyclic homooligonucleotides 1 and 2, of monomeric building block 3, (Figure 1) a 
thymidine-based nucleoside amino acid (Taa). These cyclic homooligomers 1 and 2 
were studied in detail for their conformational preferences and their biological 
activity. 
Our synthesis was started from AZT (4), which was prepared from thymidine 
following reported procedure. The oxidation of AZT and Wittig olefination of the 
resulting aldehyde was accomplished in a one-pot process using   iodoxybenzoic acid  
(IBX) in the   presence of stabilized ylide, Ph3P=CHCO2Et in DMSO to give 
exclusively trans α,β-unsaturated ester compound 5 in 65% yield (Scheme 1). Then 
both the olefin and azide were reduced under Pd-catalyzed hydrogenation condition 
using Pd/C in methanol and the resulting amino compound was protected with Boc in 
situ to get the protected nucleoside δ-amino acid TAA (Thymidine Amino Acid) 3. 
The amidine NH proton was then protected with benzyloxy methyl chloride (BOM-
Cl) using DBU as base to get 6 in 85% yield (Scheme 1). 
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The method that we planned to use for the synthesis of macrocyclic peptides is 
based on a reaction, which was expected to convert the nucleoside amino acid 
monomers directly into their cyclic homooligomers. Accordingly, saponification of 
compound 6 was performed with LiOH.H2O in Dioxan:H2O (1:1) to furnish 7. Next, 
the crude acid of 7 was treated with TFA in CH2Cl2, which yielded the TFA-salt 8 
(Scheme 2). When 8 was treated with BOP reagent, 9 was the only isolated product. 
There was no trace of cyclooligomerized product. Hydrogenation of 9 yielded 10, 
which proved the formation of bicyclic lactam. 
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Scheme 2 
 
Then we changed our strategy to get requisite cyclic homooligomers by 
preparing linear dimer. The linear dimer was prepared by conventional solution phase 
peptide synthesis methods, using TBTU and HOBt as coupling agents. Thus, 6 was 
treated with TFA in CH2Cl2 yielded the Boc-deprotected compound 11. The coupling 
between 7 and 11 was performed to furnish the linear dimer 12 in 75% yield (Scheme 
3). Stepwise saponification of 12 followed by Boc deprotection yielded 13 which on 
the subsequent step when kept for cyclisation reaction using BOP reagent under dilute 
condition, 1 and 2 were isolated in 16% and 28% yield, respectively (Scheme 3).  
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Scheme 3 
 
The conformational analysis of 1 and 2 were carried out by NMR 
spectroscopy in CDCl3 and DMSO-d6, respectively. The presence of only one set of 
peaks in 1 and 2 is consistent with a two and four fold symmetry respectively. The 
resulting structure had the NH and CO pointing approximately perpendicular to the 
plane of the macrocyclic ring with CO on the same side as the base (Figure 2). 
 
 
 
 
Figure 2. Stereo view of the 20 superimposed energy-minimized structures of 1 
 
None of these cyclic compounds showed any significant activity against 
bacteria. Finally, the BOM-protections of both the cyclic homooligomers 1 and 2 
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were removed by Pd-catalyzed hydrogenation to furnish 14 and 15 (scheme 4). The 
conformational analysis of 14 and 15 could not be carried out due to line-broadening 
and overlapping signals both in CDCl3 and DMSO-d6, making it very difficult to 
derive the spectral parameters. 
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Scheme 4 
 
In conclusion, cyclic homooligomers of nucleoside amino acid constitute a 
new class of novel molecular entities that display interesting 3-D structures, 
reminiscent of the structures of peptide nanotubes. The well-defined structures of 
these macrocyclic peptides will be useful to carry out investigations on many 
interesting molecular recognition processes.  
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